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B I O C H E M I S T R Y
Ubiquitin is a carbon dioxide–binding protein
Victoria L. Linthwaite1†, Wes Pawloski2†, Hamish B. Pegg1, Philip D. Townsend1, 
Michael J. Thomas1, Victor K. H. So1, Adrian P. Brown1, David R. W. Hodgson3,4, 
George H. Lorimer5, David Fushman2*, Martin J. Cann1,4*
The identification of CO2-binding proteins is crucial to understanding CO2-regulated molecular processes. CO2 
can form a reversible posttranslational modification through carbamylation of neutral N-terminal -amino or 
lysine -amino groups. We have previously developed triethyloxonium (TEO) ion as a chemical proteomics tool 
for covalent trapping of carbamates, and here, we deploy TEO to identify ubiquitin as a mammalian CO2-binding 
protein. We use 13C-NMR spectroscopy to demonstrate that CO2 forms carbamates on the ubiquitin N terminus 
and -amino groups of lysines 6, 33, 48, and 63. We demonstrate that biologically relevant pCO2 levels reduce 
ubiquitin conjugation at lysine-48 and down-regulate ubiquitin-dependent NF-B pathway activation. Our 
results show that ubiquitin is a CO2-binding protein and demonstrates carbamylation as a viable mechanism by 
which mammalian cells can respond to fluctuating pCO2.
INTRODUCTION
Carbon dioxide is an absolute requirement for life. However, we 
know relatively little of the mechanisms that underpin direct interac-
tions of CO2 with the cell, despite the importance of the gas to biology. 
The only identified signaling molecules that respond directly to inor-
ganic carbon [excluding a potential signaling role for carbonic anhy-
drases (1)] are the class III nucleotidyl cyclases of animals, fungi, and 
prokaryotes (2–5); a subset of connexins (typified by Cx26) in mam-
mals (6); and receptor protein tyrosine phosphatase  of mammals (7).
One hypothesis for how CO2 regulates signaling is that it mediates 
a protein posttranslational modification (PTM); CO2 might regu-
late the activity of multiple proteins and signaling pathways. There 
is direct evidence that CO2 and protein can interact through car-
bamylation of neutral lysine -amino- and N-terminal -amino 
groups and affect the activities of RuBisCO (8) and hemoglobin (Hb) 
(9), respectively. Several proteins carry a stable carbamate required 
for catalysis, e.g., urease, alanine racemase, transcarboxylase 5S, class D 
-lactamase, and phosphotriesterase (10). Reversible carbamylation 
of neutral protein amino groups could yield responses to fluctuat-
ing pCO2 (partial pressure of CO2) that might, therefore, constitute 
a widespread mechanism for protein regulation (10, 11). The hy-
pothesis centers on the dissociation of cationic ammonium 
groups to neutral amines within structurally privileged environ-
ments within CO2-responsive proteins. Carbamate formation, medi-
ated by nucleophilic attack of the neutral amines on CO2, leads to 
the formation of anionic groups, with the possibility for profound 
biological consequences as evidenced in Hb and RuBisCO. Our 
previous work developed the use of the triethyloxonium (TEO) ion 
as a tool to covalently trap the carbamate PTM on the protein (10). 
TEO is a water- soluble reagent that traps carbamates by selective al-
kylation. TEO has a t1/2 of ~6 min at pH 7.4 under aqueous conditions. 
This t1/2 permits its use as a trapping agent with mixing and pH 
control on a convenient laboratory time scale and we have used 
TEO as a tool to identify new CO2-binding proteins. Here, we have 
deployed TEO to identify mammalian CO2-binding proteins and 
identified ubiquitin (Ub) as a CO2-binding protein.
Ub is a highly conserved 8.5-kDa protein found in all eukaryotic 
cells, regulating protein activity and degradation through conjuga-
tion to target proteins. The identification of Ub as a CO2-binding pro-
tein can explain how CO2 has these diverse effects in mammalian 
cells. The ubiquitination PTM involves Ub protein covalent conjuga-
tion to a lysine side chain on target proteins. Conjugation of Ub into 
poly-Ub chains can potentially occur at every Ub lysine side chain 
and the N-terminal  amino group producing eight functionally dis-
tinct chain formations. These varying linkages underpin different 
physiological processes (12). The well-characterized poly-Ub chains 
linked via lysine-48 result in protein targeting to the proteasome for 
degradation (12), while lysine-63–linked chains regulate proteasome- 
independent reactions, including endocytosis (13). Poly-Ub conju-
gates at other lysine residues can affect the mammalian cell cycle 
(Lys11) and 5′ AMP-activated protein kinase (AMPK)–related kinases 
to regulate enzymatic activity (Lys29 and Lys33) (14).
RESULTS
TEO ion traps CO2 on Ub
A previous TEO-based chemical proteomics screen of Arabidopsis 
thaliana whole protein lysate in the presence of 20 mM NaHCO3 
identified seven CO2-binding proteins (10). A further screen iden-
tified open reading frame At3g52590 as a potential CO2-binding pro-
tein. At3g52590 encodes the UBQ1 Ub extension fusion protein (15). 
Therefore, we hypothesized that if CO2-binding sites within proteins 
are specific and conserved, Ub will represent a suitable candidate 
mammalian receptor for CO2.
A key feature of Ub is its seven conserved lysine residues (K6, 
K11, K27, K29, K33, K48, and K63) and its N-terminal -amino group, 
which can serve as ubiquitination sites in the formation of poly-Ub 
chains (Fig. 1A). Ubiquitination influences a spectrum of cellular 
processes by regulating protein function, fate, and subcellular local-
ization (16). We expressed the human Ub protein as a recombi-
nant protein in Escherichia coli. Ub was equilibrated with 25 mM 
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CO2/HCO3 at pH 7.4, and TEO was added. Trypsin was used to di-
gest the trapping reaction mixture, and liquid chromatography–
tandem mass spectrometry (LC-MS-MS) was used to analyze samples, 
followed by data analysis using Peaks (Bioinformatics Solutions Inc.). 
The data were interrogated for modifications on the N terminus and 
lysine with masses of 72.0211 Da (trapped carbamate) and 28.0313 Da 
(O-ethylation on glutamate and aspartate side chains). Two lysine 
carbamylation sites were identified (MS-MS peptide amino acids 
30 to 42 IQDKEGIPPDQQR, proposed carbamylation on K33; 
MS-MS peptide amino acids 43 to 54 LIFAGKQLEDGR, proposed 
carbamylation on K48) (Fig. 1, B and C). Within the datasets pre-
sented here, the carbamates were observed on both peptides on in-
ternal lysine residues that both exhibited a so-called missed cleavage. 
The missed cleavage is because carbamylation removes the cationic 
charge on the lysine essential for cleavage site recognition by trypsin. 
This supports the identification of carbamates on both Ub K33 and 
K48 as a missed cleavage is an otherwise rare event. The datasets also 
include peptides cleaved at K33 and K48, and these peptides do not 
carry a trapped carbamate. We performed the CO2-trapping exper-
iments on Ub with 25 mM 13CO2/H13CO3 to corroborate the car-
bamate PTMs by interrogating the MS-MS data for a 73.0211-Da 
modification. The expected +1-Da mass/charge ratio (m/z) increase 
was observed for the carbamylation sites at both K33 (Fig. 1D) and 
K48 (Fig. 1E). MS-MS peptides encompassing the N-terminal -amino 
group, K6, K11, K27, K29, and K63, were observed, but no potential 
carbamylation sites were identified by this method.
Observation of carbamate formation on Ub by 13C-NMR
We used 13C-NMR (nuclear magnetic resonance) as an orthologous 
method to confirm Ub CO2-binding sites at K33 and K48, to investi-
gate other carbamate formation sites not identified by MS-MS, and as 
a direct demonstration of the carbamate PTM on native protein. We 
initially mixed 1 mM 13C/15N-labeled Ub with 100 mM NaH13CO3 
and observed three peaks in 1D-13C NMR spectra, which were not 
present in spectra for either Ub or NaH13CO3 alone (Fig. 2A). These 
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Fig. 1. CO2 is covalently trapped on Ub. (A) Cartoon of Ub, demonstrating the seven conserved lysine ubiquitination sites and the N-terminal M1 site. Those identified 
as carbamylated through both MS-MS and 13C-NMR are shown in bold red type. The sites identified as carbamylated through 13C-NMR are shown in blue type. 
(B to E) Identification of exchangeable CO2-binding sites on Ub by MS-MS. Plots of relative fragment intensity versus m/z for fragmentation data from MS-MS identifying 
ethyl-trapped carbamate on Ub K33 (B and D) and K48 (C and E) in the presence of 12CO2 (B and C) or 13CO2 (D and E). Peptide sequences indicate the identification of 
predominant +1y (red) +1b (blue) ions by MS-MS shown in the plot. The modified residue is displayed in bold. Kcarb.Et indicates the molecular weight difference between 
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Fig. 2. CO2 forms carbamates on Ub. (A) Ub carbamates are observed with NaH13CO3. Two 1D 13C-NMR spectra of 15N/13C-labeled Ub WT and the same sample ex-
changed into an identical buffer with 100 mM NaH13CO3 are overlaid. The background 13CO2 and H13CO3− are observed along with carbamates. (B) The carbamate signal 
intensity is affected by the NaH13CO3 concentration. The carbamate region from 1D 13C-NMR spectra is shown for buffers prepared with 5 mM Ub WT varying NaH13CO3 
concentration, and the intensities were standardized to the Arg C resonances. The carbamate signals were identified by consecutive Lys to Arg mutations to make Ub 
mutant variants K48R (C), K48R/K33R (D), K48R/K33R/K6R (E), K48R/K33R/K6R/K63R (F), and K0 (all seven Lys residues mutated to Arg). (G) K0 Ub was mixed with one 
equivalent of sodium cyanate to carbamoylate the N-terminal amine and compared to unmodified K0 Ub. A low-intensity 13C carbamate signal [marked with * in (B)] is 
observed at 5 mM Ub, but not 1 mM Ub, from the same batch (fig. S1) or other Ub mutants (C to G); the signal could be attributed to a minor population of carbamates 
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consistent with the empirical range for carbamate PTMs (17). Un-
labeled Ub (1 or 5 mM) was subsequently exchanged into buffers 
containing 20, 50, or 100 mM NaH13CO3, and we observed that 
the intensities of these carbamate signals increased with increasing 
[NaH13CO3] or Ub concentration (Fig. 2B and fig. S1), supporting 
the hypothesis that they are the product of reversible carbamate for-
mation on Ub. The ratios of the peak intensities were unaltered at 20, 
50, or 100 mM NaH13CO3. We therefore used 100 mM NaH13CO3 
to identify the carbamate-forming residues. Experiments performed 
with the double mutant Ub K48R/K6R yielded partial reductions in 
the two signal intensities at 164.77 and 164.96 ppm (fig. S2A). In 
a duplicate experiment with uniformly 15N-labeled Ub K48R/K6R, 
these remaining signals were split into doublets; the observed split-
tings of ~18.5 Hz were consistent with a one-bond 15N-13C coupling 
(fig. S2B), indicating that the 13C atoms responsible for these signals 
are directly bonded to 15N atoms, and confirm that these are carba-
mate signals. To unambiguously identify the carbamate signals, we 
performed consecutive lysine to arginine Ub mutations starting with 
K48R (Fig. 2C) and adding K33R (Fig. 2D), K6R (Fig. 2E), and K63R 
(Fig. 2F), which revealed that the signals at 164.77 and 164.96 ppm 
were constituted of overlapping carbamate signals from K6/K33 and 
K48/K63, respectively. The 13C-NMR spectrum of the quadruple mu-
tant (K6R/K33R/K48R/K63R) matched the spectrum of a lysine-free 
Ub (K0) (Fig. 2G). This observation demonstrates that carbamylation 
was not evident at K11, K27, or K29. Removal of all Ub lysines in Ub 
K0 did not affect the 13C-NMR carbamate resonance at 163.25 ppm. 
The only potential nucleophilic nitrogen atoms remaining in Ub K0 
are the N-terminal amino group and, possibly, the imidazole of H68. 
N-acetyl-l-histidine cannot form adducts with CO2 (18) but is identi-
fied in the binding pockets of proteins that can interact with CO2 (19). 
An H68A mutation was introduced into Ub to examine whether H68 
(the single histidine residue in Ub) was responsible for this remain-
ing signal. This mutation altered the population of carbamylated 
K6, likely reflecting an altered pKaH of K6 due to the proximity of its 
-amino group to the imidazole of H68, but did not affect the reso-
nance at 163.25 ppm (fig. S3). We reacted Ub K0 with one equiv-
alent of sodium cyanate, which ablated the carbamate resonance at 
163.25 ppm, identifying it as originating from carbamylation of the 
N-terminal amine (residue M1; Fig. 2H).
The pKaH value for the lysine -amino group is substantially above 
physiological pH. As carbamylation depends on the dissociation of 
the -amino moiety to a neutral group, those lysines with lower 
-amino pKaH values are potentially more likely to form carbamates. 
We therefore determined the pKaH for lysine -amino groups and the 
N-terminal amine in Ub. Lysine-specific N or C chemical shift data 
were obtained over the pH range from 8.6 to 12.3 and fit to a Henderson- 
Hasselbalch model to extract the pKaH for each -amino group (and 
the -amino group of M1) (fig. S4). The data demonstrate an ordering 
of pKaH of K6 < K48 < K33 < K63 < K27 < K11 < K29 (Table 1), in 
agreement with a recent report (20). The observation of carbamyla-
tion on K6, K33, K48, and K63 using 13C NMR, therefore, matches the 
ordering of pKaH for each -amino group. In conclusion, human Ub 
has been identified, through MS-MS and 13C-NMR spectroscopy, to 
be capable of binding CO2 through carbamate PTM formation.
Carbamate formation down-regulates Ub conjugation at 
K48 in vitro
We hypothesized that Ub carbamylation would affect poly-Ub for-
mation. Ubiquitination occurs through the sequential activity of a 
Ub-activating enzyme (E1), a Ub-conjugating enzyme (E2), and a 
Ub ligase (E3) (21). E1 forms a thioester between a catalytic cysteine 
and glycine-76 at the Ub C terminus. E1 transfers Ub via G76 to a 
catalytic cysteine on E2 and forms an E2-Ub thioester complex. E3s 
bind this complex and substrate and enable formation of an iso-
peptide bond between the Ub C-terminal carboxyl group and the 
-amino group of a substrate lysine or an N-terminal amino group. 
Successive reaction rounds can produce poly-Ub chains linked via the 
seven Ub lysine residues or the N terminus of M1. We hypothesized 
that carbamate formation on Ub would alter the charge/binding ca-
pacity of the modified lysine -amino group and therefore down- 
regulate poly-Ub chain formation by blocking the transfer of free Ub 
onto a target Ub molecule. Ub conjugation at K48 is well characterized 
in vitro and in vivo, particularly concerning proteasomal function 
(22). We identified K48 as a site for carbamylation by TEO-trapping 
(Fig. 1, C and E) and 13C-NMR spectroscopy (Fig. 2C). Therefore, 
we selected Ub conjugation at K48 to investigate the biochemical rel-
evance of Ub carbamylation. A carbamate was identified on Ub K63 
by 13C-NMR spectroscopy (Fig. 2F), but not TEO trapping. There-
fore, we selected Ub conjugation at K63 as an additional site for anal-
ysis. Conjugation assays at both Ub K48 and Ub K63 used the mE1 
protein as a Ub-activating enzyme (23). Ub conjugation at specific 
lysine side chains can be investigated using E2 and E3 enzymes spe-
cific for conjugation at that site. Conjugation at Ub K48 used the 
E2-25K protein, which functions as both an E2 and an E3 enzyme, 
while conjugation at Ub K63 used the UEV1-Ubc13 heterodimer. 
These assays were performed over a concentration range that incor-
porated physiologically relevant CO2 concentrations (a reference 
range of 1.8 to 2.3 mM dissolved CO2 corresponding to a pCO2 of 
4.6 to 6.0 kPa) as well as pathophysiological hypocapnic CO2 (<1.8 mM 
dissolved CO2) and up to severe pathophysiological hypercapnic 
CO2 (3.0 mM dissolved CO2) (24). pH was monitored before, during, 
and at the end of each assay and was within ±0.1 pH units. Any ob-
servations are therefore independent of pH.
We observed an approximate 12% decrease in di-Ub formation 
at K48 over 0.0 to 3.0 mM CO2 (Fig. 3, A and C), consistent with an 
inhibition of E2-25K activity due to the carbamate on Ub K48. An 
increase in CO2 from 1.8 to 3.0 mM CO2 (corresponding to in vivo 
hypercapnia) revealed decreased di-Ub formation at K48. Reduc-
tions in CO2 below 1.8 mM (corresponding to in vitro hypocapnia) 
Table 1. pKaH values for Ub lysine -amino groups and -amine of 
N-terminal M1.  The reported errors in pKaH values reflect errors in 
determining the 15N or 13C chemical shifts alone and do not account for 
errors in pH measurements at elevated pH (see Supplementary Materials 
and Methods). 
Residue pKaH
M1 9.19 ± 0.05
K6 10.47 ± 0.02
K48 10.53 ± 0.02
K33 10.88 ± 0.03
K63 11.03 ± 0.02
K27 11.2 ± 0.1
K11 11.47 ± 0.03
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showed increased di-Ub formation at K48. We observed no change 
in di-Ub formation at K63 over 0.0 to 3.0 mM CO2 (Fig. 3, B and C). 
Analysis of the data for di-Ub formation at K48 by one-way analysis 
of variance (ANOVA) demonstrated a significant decrease in di-Ub 
formation between 1.8 and 3.0 mM CO2. Di-Ub formed represented 
~30% of the input Ub, suggesting that the observations are robust 
and not reflective of a minor reaction. Thus, experiments in vitro 
demonstrate that pathophysiologically relevant changes in CO2 sig-
nificantly alter Ub conjugation at K48.
It is formally possible that the influence of altered CO2 on Ub 
conjugation at K48 is due to CO2 binding to an alternative assay com-
ponent to Ub. The Ub-activating enzyme, mE1, is common for con-
jugation at both K48 and K63 and is therefore unlikely to be a CO2 
target due to no observed influence of CO2 in the K63 conjugation 
assay. We used TEO-based trapping in an attempt to identify a po-
tential CO2-binding site on E2-25K to investigate the possibility that 
the E2/E3 enzyme for K48 conjugation is a CO2 target. TEO trap-
ping and subsequent MS-MS failed to identify any E2-25K peptides 
with trapped carbamates (174 peptides with 94% coverage of the 
E2-25K protein).
Note that CO2 did not influence K63 conjugation under the as-
say’s conditions. The carbamate on K48 may be more stable than that 
on K63, but this awaits further investigation. Therefore, while car-
bamates on both K48 and K63 are detectable by 13C-NMR, we pro-
pose that only the carbamate at K48 has a sufficient residence time 
to influence Ub conjugation over the time scale of the in vitro assay.
Carbamate formation down-regulates Ub conjugation at Ub 
K48 in cellulo
We hypothesized that exposure of cells to elevated CO2 would affect 
Ub-dependent processes in the cell. Ubiquitination of proteins reg-
ulates nuclear factor B (NF-B) signaling (17). Two NF-B acti-
vation pathways have been described: the canonical (classical) and 
noncanonical (alternative) pathways. Various ligands, including tu-
mor necrosis factor– (TNF-), associated with local inflammatory 
and immune responses, induce the activation of the canonical NF-B 
pathway. NF-B is maintained in the nonactivated state in the cyto-
plasm through binding to the inhibitor of NF-B (IB) proteins. 
Phosphorylation of IB proteins results in ubiquitination with K48-
linked poly-Ub and subsequent degradation of IB by the proteasome. 
NF-B is subsequently transported to the nucleus, where it activates 
a transcriptional response.
Elevated CO2 suppresses NF-B–mediated transcription (25–28). 
This suppression is proposed to have therapeutic potential (29) 
but remains controversial (30). Regardless of the controversy, the 
mechanism(s) by which CO2 influences NF-B–mediated transcrip-
tion is unknown. We investigated whether Ub was able to determine 
responses of NF-B–mediated transcription to CO2. Experiments 
used human embryonic kidney (HEK) 293 cells (NF-B/293/GFP-
Luc) transduced with HIV-based pseudoviral particles packaged with 
a lentivector that coexpressed destabilized copGFP [but whose stabil-
ity is not altered by pH (31)] driven by the minimal cytomegalovirus 
promoter (mCMV) in conjunction with four copies of the NF-B 
consensus transcriptional response element upstream of mCMV. We 
exposed NF-B/293/GFP-Luc cells to increasing concentrations of 
TNF- under culture media equilibrated to normocapnic [5% (v/v) 
CO2] or hypercapnic [10% (v/v) CO2] conditions (endpoint pH 7.5) 
(Fig. 4A). Physiological hypercapnia occurs above 45 mmHg pCO2. 
We selected cell culture conditions of 10% (v/v) CO2 as representa-
tive of CO2 levels encountered in disease (32). Extracellular pH was 
monitored before, during, and after assays and was constant across 
all conditions. Cells were permitted to undergo intracellular pH (pHi) 
homeostasis using our previously established methodology to ensure 
that changes in pHi did not influence the results (33). Resting pHi 
for HEK 293 cells (~7.4) is consistent with our in vitro assay con-
ditions (34). NF-B–dependent green fluorescent protein (GFP) re-
porter activity was suppressed at 10% (v/v) compared to 5% (v/v) 
CO2 as hypothesized.
We transfected NF-B/293/GFP-Luc cells with plasmids encod-
ing wild-type (WT) Ub, a mutant K48R Ub, a mutant K63R Ub, or 
an empty vector. We hypothesized that overexpression of K48R Ub 
would alter the relative response of the NF-B pathway to elevated 
CO2. In contrast, for the cases of WT Ub and Ub K63R, we expected 
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Fig. 3. CO2 modifies Ub conjugation at K48 in vitro. A plot of the ratio of di-Ub 
formed in the presence of added CO2 compared to atmospheric CO2 against the 
concentration of added CO2. Values are normalized to 1 using the value at 1.8 mM 
CO2. 0 corresponds to atmospheric CO2. (A) Ub conjugation at K48 [mean ± 95% 
confidence interval (CI); *P < 0.01, one-sample t test, theoretical mean = 1.000, 
t > 3.122, df = 12]. (B) Ub conjugation at K63 (mean ± 95% CI). (C) Comparison of 
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the NF-B response to be insensitive to CO2 in vitro (Fig. 3, B and C). 
We observed a ratio of fluorescence reporter activity at 5% (v/v) 
compared to 10% (v/v) >1 in vector-transfected cells, consistent with 
a reduction in NF-B–dependent transcription (Fig. 4B). A similar 
observation was made in cells transfected with WT or a K63R Ub. How-
ever, we observed a ratio of fluorescence reporter activity at 5% (v/v) 
compared to 10% (v/v) not significantly different from 1.0 in K48R- 
transfected cells, consistent with no change in NF-B–dependent 
transcription. This finding suggests Ub K48 to be the target for CO2 
in the NF-B–dependent transcriptional response to hypercapnia. 
We speculate that K48R Ub might be introduced into endogenous Ub 
chains at a rate sufficient to permit eventual fluorescence reporter ac-
tivation and ablate the impact of CO2 on poly-Ub formation. Analy-
sis of the ratio of production of the transfected Ub protein at 5% (v/v) 
versus 10% (v/v) CO2 demonstrated no significant difference be-
tween WT Ub, K48R Ub, and K63R Ub; thus, differences in protein 
production do not explain these results (Fig. 4C). A faint band was 
visible above the predominant signal in the WT Ub–transfected 
sample. The identity of the protein in this band is not known, but its 
density does not alter the experimental findings. Data were reported 
as ratios of fluorescence reporter activity at 5% (v/v) compared to 
10% (v/v) CO2, as the variation in raw values for fluorescence re-
porter activity was greater than the change in ratio. All values were 
normalized to total loaded protein. This variation was likely due to 
variation in Ub plasmid transfection efficiency and Ub protein pro-
duction. We cannot, therefore, rule out whether the influence of CO2 
on reporter activity occurs specifically at 5% (v/v) versus 10% (v/v) 
CO2 (or both).
We investigated whether Ub conjugation on IB was sensitive to 
elevated CO2. IB is conjugated with Ub under basal cell conditions 
that form a high–molecular weight complex, and activation of the 
NF-B pathway can enhance this conjugation (35). We treated HEK 
293 cells with or without TNF- at 5% (v/v) versus 10% (v/v) CO2. 
TNF- treatment was optimized such that bulk IB was not degraded 
and thus able to be analyzed for Ub conjugation. Western blot anal-
ysis demonstrated approximately equivalent amounts of endogenous 
Ub and IB under the varying conditions (Fig. 5A, -IB and -Ub 
Input, and fig. S5). A faint band was visible below the predominant 
signal in the 10% (v/v) CO2 input sample analyzed with an -Ub anti-
body. The identity of the protein in this band is not known, but its 
density does not alter the experimental findings. We analyzed IB by 
Western blot after immunoprecipitation with -Ub antibody to iden-
tify an IB-Ub conjugate. A high–molecular weight IB-Ub conjugate 
was observed in the absence of TNF- at 5% (v/v) CO2 as previously 
observed (35) (Fig. 5A, arrow, top, and fig. S5). The IB-Ub conjugate 
was not observed in the presence of TNF- at 5% (v/v) CO2, consist-
ent with its degradation in the proteasome. Significantly, no high–
molecular weight IB-Ub conjugate was observed in the absence of 
TNF- at 10% (v/v) CO2. This observation is consistent with a de-
crease in Ub conjugation to IB at elevated CO2 and the in vitro data 
of Fig. 3A. The experimental observations were independent of small 
variations in input Ub and IB evident across the biological replicates. 
We permitted the higher Ub input signal level at 10% (v/v) CO2 to be 
certain that the loss of the high–molecular weight IB-Ub conjugate 
was not an artefact of a lower input Ub. Note that under the conditions 
of this experiment, the IB-Ub conjugate was observed to degrade in 
the presence of TNF- at 10% (v/v) CO2. Thus, the observation of a 
change in the formation of an IB-Ub complex was, by necessity, 
made in the absence of TNF-. Future developments will be required 
to observe changes in IB-Ub conjugation in the presence of TNF-.
We assessed the impact of 10% (v/v) CO2 on IB degradation in 
response to TNF-. A comparison was made to ambient CO2 to in-
crease the likelihood of observing a difference (25). HEK 293 cells 
transfected with Ub WT or Ub K48R were compared for their sen-
sitivity to elevated CO2 after stimulation with TNF- (0.26 ng ml−1) 
and harvesting cells at 30 min (Fig. 5B). We observed that the ratio 
of the impact of elevated CO2 for Ub K48R:Ub WT was consistently 
<1, indicating that the CO2 effect was more significant for Ub WT 
than Ub K48R.






























   
)
−1
5% CO2 10 % CO2




































































5 55 10 10 10
10
Fig. 4. CO2 modifies signaling dependent on K48-linked poly-Ub in cellulo. 
(A) Plot of the fluorescence reporter activity for untransfected NF-B/293/GFP-Luc 
cells against TNF- at 5 and 10% (v/v) CO2. The dotted line indicates the 95% confi-
dence interval. (B) Plot of the ratio of fluorescence reporter activity for transfected 
NF-B/293/GFP-Luc cells at 5 and 10% (v/v) CO2 treated with TNF- (30 ng ml−1). 
Cells were transfected with vector only or with a plasmid expressing WT Ub (WT), 
mutant K48R Ub (K48R), or mutant K63R Ub (K63R) (mean ± 95% CI; *P < 0.02, 
one-sample t test, theoretical mean = 1.000, t > 3.027, df = 3 to 7). (C) Plot of the 
ratio of Ub expression at 5% (v/v) versus 10% (v/v) CO2 for three independent 
samples from (B) expressing WT, K48R, or K63R Ub (mean ± 95% CI; #P > 0.05, one- 
sample t test, theoretical mean = 1.000, t < 1.896, df = 2). The immunoblot below 
shows mono-Ub protein detected with an -HA-tag antibody at the indicated 
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We further assessed the impact of 10% (v/v) CO2 on p65 nuclear 
localization in response to TNF-. HEK 293 cells transfected with 
Ub WT or Ub K48R were compared for their sensitivity to elevated 
CO2 after stimulation with TNF- (10 ng ml−1) and harvesting cells 
at 30 min (Fig. 5B). We observed that the ratio of the impact of ele-
vated CO2 for Ub K48R:Ub WT was also consistently <1, indicating 
that Ub K48R altered the sensitivity of the experiment to CO2. In 
this case, the result indicates that Ub K48R overexpression increased 
the sensitivity of p65 nuclear localization to CO2. Therefore, it is 
interesting to note that CO2, through Ub K48, might have varying 
effects at different parts of the NF-B pathway depending on its local 
roles. For example, Ub K48 is linked to protein nuclear export (36), and 
these processes might influence p65 nuclear localization and down-
stream effects at chromatin. However, whatever the impact of CO2 on 
varying parts of the TNF- response, all with their characteristic response 
and dynamics, the result is the down-regulation of NF-B expression.
Considering the observations that Ub binds CO2, has its bio-
chemistry altered by CO2 in vitro and in vivo and overexpression of 
a mutant Ub that cannot bind CO2 in cellulo, ablates a response to 
hypercapnia, and alters the CO2 response as varying parts of the re-
sponse pathway, we conclude that Ub is a CO2-binding protein.
DISCUSSION
The sensing of bioactive gases is of fundamental importance to 
mammalian physiology. Soluble guanylate cyclase is the nitric oxide 
receptor (37), while oxygen sensing is achieved by PHD1-3 cata-
lyzed prolyl hydroxylation of hypoxia-inducible factors (HIF-1, 
HIF-2, and HIF-3), which facilitates HIF- regulation in the 
PHD1-3–HIF-–pVHL signaling axis (38, 39). Analysis of tran-
scriptional responses to elevated CO2 in Drosophila identified up- 
regulated gene ontology (GO) families relating to metabolic functions. 
In contrast, most of the down-regulated GO families had either 
immune- or fertility-related annotations (40). Similar experiments in 
Caenorhabditis elegans identified 488 up- or down-regulated genes 
after 1-hour exposure to elevated CO2 (41). In addition to transcrip-
tion responses, physiological responses to hypercapnia in Drosophila 
included altered embryo morphogenesis, egg laying, egg hatching, 
and innate immune responses. C. elegans responses included altered 
body muscle organization, slowed development, reduced fertility, and 
increased life span. No candidate CO2-binding protein that might 
explain its various physiological effects has been identified to date. Ub 
fulfils the criteria of a CO2-binding protein and might explain the 
diverse physiological impact of hypercapnia.
Elevated CO2 is reasonably well tolerated in mammals, while Ub 
conjugation is an essential cellular function. Therefore, it is significant 
that carbamate formation on Ub across the range of 0 to 3 mM CO2 
reduces Ub conjugation at K48 by just over 10%. Such a reduction in 
Ub conjugation may be sufficient to have a physiological impact, but 
not too significant an effect of being lethal. The specific carbamate for-
mation sites on Ub also guide future avenues of investigation for mo-
lecular responses to CO2. Carbamate formation at Ub K48 suggests an 
influence on signaling pathways regulated by proteasomal degrada-
tion, as evidenced here for NF-B–dependent transcription. We can-
not exclude the possibility that carbamylation at K48 (or another site) 
acts to expand the Ub code in the presence of conjugates at other sites 
(42). Carbamate formation at Ub K6 and K33 suggests a mechanism 
by which hypercapnia might influence mitophagy/xenophagy and 
post-Golgi membrane protein trafficking, respectively (16, 43). Also, 
of note, Ub N-terminal carbamylation might be physiologically im-
portant because the head-to-tail linked (also known as “linear”) Ub 
chains also regulate immune signaling (44). The impacts of carbam-
ylation upon Ub polymerization in vitro and in vivo at these sites await 
future investigation. No motif identifying the propensity of a site to 
carbamylation is evident, most likely because carbamylation depends 
on a structurally privileged local environment that lowers local pKaH, 
rather than a defined primary motif. Carbamylation in Ub-like mole-
cules (e.g., prokaryotic Ub-like protein) will therefore require future 
experiments and is not currently amenable to prediction.
The identification of Ub as a CO2-binding protein might also de-
cipher conflicting data surrounding the identity(ies) of the site(s) of 
action of CO2 along the NF-B pathway. Several studies suggest that 
CO2 affects the canonical NF-B pathway components, including 
IB- (45) and the noncanonical pathway (25, 46, 47). In the ca-
nonical pathway, in addition to IB, the E3 ligase cIAP1 and RIPK1 
serine-threonine kinase at the TNF receptor complex require Ub 
K48-linked poly-Ub for pathway activation (48). In the noncanonical 
pathway, ubiquitination with K48-linked poly-Ub of TRAF2 by cIAP1 
and of p100 for its processing to p52 is required for activation (49). 
Ub is the common entity that could underpin explanations as to why 
both pathways are sensitive to CO2. The future selection of other 

































Fig. 5. K48-linked poly-Ub alters sensitivity to CO2 in cellulo. (A) Interaction of 
IB with Ub. Coimmunoprecipitation of endogenous IB and Ub from HEK 293 cells. 
The labels on the figure are as follows: Input: immunoblot of endogenous IB and 
Ub; IP -Ub WB -IB: immunoblot performed using an -IB antibody after immuno-
precipitation with an -Ub antibody; CO2 (% v/v): gas conditions under which the 
experiment was performed; TNF-: presence or absence of TNF- (30 ng ml−1); 
arrow in -IB, Input: IB protein; arrow in top panel: IB-Ub conjugate; kDa: 
molecular weight markers. See also fig. S4. (B) Plot of the impact of elevated CO2 in 
HEK 293 cells transfected with Ub K48R compared to Ub WT on the ratio of the re-
sponse for IB degradation and p65 nuclear localization (mean ± 95% CI; *P < 0.05, 
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In summary, Ub is a CO2-binding protein through carbamate 
formation. Physiological levels of CO2 regulate Ub conjugation at 
K48 in vitro, and overexpression of a Ub mutant that is unable to con-
jugate at the K48 CO2-dependent site ablates a CO2-dependent phe-
notype in cellulo. On the basis of our findings, we postulate that the 




All CO2-trapping experiments were carried out with recombinant 
protein (500 g) in phosphate buffer (3 ml, 50 mM, pH 7.4). This 
solution was transferred to a potentiometric titrator (902 Titrando; 
Metrohm) and incubated at 25°C with stirring. A freshly made solu-
tion of TEO tetrafluoroborate (Et3OBF4; 280 mg, 1.47 mmol) in phos-
phate buffer (1 ml) was added stepwise with a constant pH being 
maintained (pH 7.4) through the slow addition of 1 M NaOH solu-
tion via the automatic burette. The reaction mixture was stirred, with 
the pH being maintained, for 1 hour after the final Et3OBF4 addi-
tion to ensure that all TEO was hydrolyzed. The reaction mixture 
was then dialyzed against dH2O (1 liter) overnight.
Mass spectrometry
The water was removed from a postdialysis-trapped sample super-
natant using a centrifugal vacuum concentrator. Protein was resus-
pended in urea solution (8 M, 500 l), and disulfide bonds in the 
sample were reduced using dithiothreitol (DTT; 25 mM final con-
centration) at 37°C for 1 hour. The resulting free thiol groups were 
alkylated using iodoacetamide (40 mM) in the dark for 1 hour at 
room temperature. The sample was diluted to 1 M urea with ammonium 
bicarbonate buffer and digested with trypsin gold [mass spectrometry 
grade, Promega; 1:25 (w/w) ratio to protein] overnight at 37°C. The 
solution of digested proteins was desalted and resolved using a C18 
column (ZipTip, Merck Millipore), dried down, and resuspended 
in 4% (v/v) acetonitrile and 0.05% (v/v) trifluoroacetic acid. The eluted 
peptides were analyzed by LC-MS-MS on a QStar Pulsar QTOF 
mass spectrometer (Sciex) coupled to nano-LC instrument. Peptides 
were eluted from an LC gradient from 3 to 80% (v/v) acetonitrile 
and injected online to the mass spectrometer [information dependent 
acquisition (IDA) mode, mass range of 300 to 1600 Da, MS accumu-
lation time of 1 s, ion source voltage of 2300 V, three MS-MS spectra 
per cycle, MS-MS mass range of 100 to 1600 Da, and MS-MS accumula-
tion time of 3 s]. The post–ESI-MS-MS raw data files were converted 
into .mgf files using the freeware MSConvert provided by ProteoWizard 
(50) and analyzed using PEAKS Studio 10.5 software (51) including 
the variable modifications ethylation (28.0313 Da at D or E), carboxyethyl-
ation [72.0211 for 12CO2 or 73.0211 for 13CO2 at K or protein N-terminal 
groups], oxidation (M), acetylation (N terminus), and the fixed modifi-
cation carbimidomethyl (C). These data were then refined using a 
false discovery rate of 1% and a PTM AScore of 50.
NMR spectroscopy
NMR experiments were performed on a Bruker Avance-III 800 MHz 
spectrometer equipped with a QCI cryoprobe. All carbamylation ex-
periments were performed at 37°C in a buffer containing 20 mM so-
dium phosphate, 0.02% (w/v) NaN3, and 10% (v/v) D2O at pH 7.4. 
The buffer was prepared with 100 mM NaH13CO3 unless otherwise 
indicated. 13C spectra were acquired with a 45° pulse, spectral width of 
12820.5 Hz, an acquisition time of 847 ms for 21,738 points, and a 
recycle delay of 2.5 s. Spectra with 13C- and 15N-labeled Ub were ac-
quired with 15N decoupling during an 80-ms acquisition period. All 
processing was performed with Mestrelab MNova within an NMRBox 
(52) environment. Ub Lys pKaH values were determined by follow-
ing either N or C/C chemical shifts measured via triple- resonance 
H2CN experiments (H2CN) (53) or 1H-13C HSQC experiment, 
respectively, within the pH range from 8.6 to 12.3 at 23°C. Initially, 13C/15N 
Ub was exchanged into 5 mM N-cyclohexyl-2-aminoethanesulfonic 
acid (CHES)/5 mM N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) 
buffer at pH 10.5 and separated into two 500-l 1 mM Ub aliquots 
that were run as two divergent samples for lower or higher pH mea-
surements. After each experiment, these samples were consecutively 
exchanged into the same buffer with either increasing or decreasing 
pH by the addition of 0.1 M HCl and 0.1 M KOH in approximately 
0.3 (H2CN) or 0.4 (HSQC) pH unit steps. D2O was added to each 
sample to a final concentration of 5% (v/v). The pKaH values were ob-
tained by fitting the observed signal shifts to a Henderson-Hasselbalch 
model. The errors in reported pKaH values (Table 1) for each residue 
were assessed by fitting 2000 Monte Carlo–generated synthetic data-
sets, in which Gaussian noise was added to the chemical shifts accord-
ing to the resolution in the respective H2CN or 1H-13C HSQC spectra.
Recombinant protein production
WT human Ub derived from pET15 (54) was cloned into the Nde I 
and Bam HI restriction sites of pET28a with a stop codon intro-
duced to preclude expression of the His6 affinity tag. Mutant hu-
man Ub–expressing constructs were derived from the WT plasmid 
by site-directed mutagenesis. Recombinant WT and mutant Ub were 
expressed as untagged proteins from pET28a in E. coli BL21(DE3) 
at 20°C for 16 hours with 0.4 mM isopropyl--d-thiogalactoside 
(IPTG). Pelleted bacteria (10 ml) were suspended in sonication buffer 
(phosphate-buffered saline, 50 ml) including SIGMAFAST Protease 
Inhibitor Cocktail Tablets, lysed by sonication (180 s on ice), and cen-
trifuged (50,000g, 40 min, 4°C). The supernatant was incubated on 
ice with the addition of 70% (w/v) perchloric acid with vigorous stir-
ring until solution pH dropped to 4.5. The solution was left to stir for 
1 hour and then centrifuged to remove precipitate (5000g, 40 min, 
4°C). The remaining supernatant was dialyzed against 50 mM ammo-
nium acetate buffer overnight (1 liter, 4°C). Sample was centrifuged 
(50,000g, 40 min, 4°C), and supernatant was dialyzed against purifica-
tion buffer for 8 hours (10 mM tris, pH 7.6). Protein from this sample 
was then purified using size exclusion chromatography (Superdex 75).
mE1 was expressed from pET28a in E. coli BL21(DE3) at 16°C for 
20 hours with 0.5 mM IPTG (55). Pelleted bacteria (10 ml) were sus-
pended in sonication buffer [50 ml; 50 mM tris-HCl (pH 8), 150 mM 
NaCl, 0.1% (v/v) Triton X-100, 1 mM EDTA, 1 mM DTT, phenylmeth-
ylsulfonyl fluoride (PMSF; 0.1 mg/ml)], lysed by sonication (180 s on 
ice), and centrifuged (50,000g, 40 min, 4°C). Protein was affinity- 
purified from the supernatant using a 5-ml HisPrep HP Ni-NTA col-
umn (GE Healthcare) on an AKTA Pure chromatography system at 
2 ml min−1 (GE Healthcare). Eluted protein was concentrated and 
buffer-exchanged with 10 mM tris-HCl (pH 8), 1 mM EDTA, and 
1 mM DTT before additional purification by ion exchange chroma-
tography and size exclusion chromatography at 0.5 ml min−1.
E2-25K and Ubc13 were expressed from pGEX-4T in E. coli 
BL21(DE3) at 16°C for 20 hours with 0.5 mM IPTG (56, 57). Pelleted 
bacteria (10 ml) were suspended in sonication buffer [50 ml; 50 mM 
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(180 s on ice), and centrifuged (50,000g, 40 min, 4°C). Protein was 
affinity-purified from the supernatant using a 5-ml glutathione 
S-transferase (GST)–agarose column (Thermo Fisher Scientific) on an 
AKTA Pure chromatography system at 1 ml min−1 (GE Healthcare).
pET28a-UEV1 was a gift from Cheryl Arrowsmith (Addgene plas-
mid #25619; http://n2t.net/addgene:25619; RRID:Addgene_25619). 
UEV1 was expressed from pET28a in E. coli BL21(DE3) at 16°C for 
20 hours with 0.5 mM IPTG. Pelleted bacteria (10 ml) were suspended 
in sonication buffer [50 ml; 20 mM tris 8.0, 10% (v/v) glycerol, 300 mM 
NaCl, 2 mM 2-mercaptoethanol, 0.2 mM tris(2-carboxyethyl)phosphine, 
0.1% (v/v) Triton X-100, and 2 mM PMSF]. Protein was affinity-purified 
from the supernatant using a 5-ml HisPrep HP Ni-NTA column (GE 
Healthcare) on an AKTA Pure chromatography system at 2 ml min−1 
(GE Healthcare). The His6 affinity tag was removed using tobacco 
etch virus (TEV) protease (Sigma-Aldrich), and the protein was 
passed over a second Ni-NTA column. Protein from this sample 
was then purified by size exclusion chromatography (Superdex 75).
Ub conjugation assays
Conjugation assays were performed with 0.2 mM Ub, 2.5 mM aden-
osine 5′-triphosphate (ATP), 2.5 mM MgCl2, and 0.5 mM DTT in 
250 mM tris-HCl (pH 7.5). Conjugation reactions at Ub K48 in-
cluded 0.1 M mE1 and 20 M E2-25K (also known as Ube2k). Con-
jugation at Ub K63 included 1 M mE1, 8 M Ubc13, and 8 M UEV1. 
Experiments were performed from 0 to 50 mM CO2/HCO3− with 
[anion] maintained at 50 mM with supplementary Cl−. Reactions 
were performed in 50-l volumes at 37°C for 30 min and started with 
mE1 addition. Reactions were stopped with 1× Laemmli buffer and 
electrophoresed by SDS–polyacrylamide gel electrophoresis for im-
aging and quantification using ImageJ (58).
Western blotting
Polyacrylamide gels [1.0 mm; 10% (v/v) bis-acrylamide resolving 
and 5% (v/v) bis-acrylamide stacking] were poured using the Mini- 
PROTEAN Tetra Electrophoresis System. Samples were mixed 1:1 (v:v) 
with loading buffer [50 mM tris-HCl (pH 6.8), 2% (w/v) SDS, 0.1% 
(w/v) bromophenol blue, 10% (v/v) glycerol, and 100 mM DTT], 
incubated at 95°C for 5 min, and run at 20 V cm−1 in running buffer 
[25 mM tris-HCl (pH 6.8), 200 mM glycine, 0.1% (w/v) SDS]. Proteins 
were transferred at 2 V cm−1 at 4°C overnight in transfer buffer [25 mM 
tris-HCl (pH 8.5), 190 mM glycine, and 15% (v/v) methanol]. Mem-
branes were washed for 5 min in TBS-T [25 mM tris-HCl (pH 7.5), 
150 mM NaCl, 0.05% (v/v) Tween 20] and incubated in blocking 
buffer [5% (w/v) nonfat milk in TBS-T] for 2 hours at room temperature. 
Membranes were washed three times in TBS-T for 10 min each and 
then probed with primary antibody diluted in blocking buffer. Membranes 
were washed again with TBS-T and then probed with secondary antibody 
diluted in blocking buffer. Membranes were again washed with TBS-T 
before developing with ECL Western Blotting Detection Reagent at 
room temperature. Blots were imaged and quantified using ImageJ 
(58). The signal for the -HA (human influenza hemagglutinin) antibody 
used for the quantitative Western blot of Fig. 4C was confirmed to lie 
on a straight line of a plot of Western blot signal versus loaded protein 
lysate for which the slope was significantly nonzero (fig. S6). The con-
ditions of the Western blot were therefore suitable for quantitation.
GFP reporter assay
NF-B/293/GFP-Luc cells (System Biosciences) were cultured until 
80% confluency in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% (v/v) heat-inactivated newborn calf serum, 
100 M nonessential amino acids, 50 U of penicillin, and 50 g of 
streptomycin. Cells were passaged into 24-well plates and allowed 
to adhere for 6 hours before transfection. Transfections were per-
formed using Lipofectamine 3000 (Invitrogen) in Opti-MEM media 
(Gibco) with 1 g of DNA per well. Human Ub WT and K48R were 
expressed from pRK5 (60). A plasmid expressing human Ub K63R 
was generated from the WT template by site-directed mutagenesis. 
Cells were incubated at 37°C and 5% (v/v) CO2 for 20 hours, and then 
the medium was exchanged for DMEM without phenol red contain-
ing 25 mM Hepes buffer (pH 7.4) supplemented with 10% (v/v) heat- 
inactivated newborn calf serum, 100 M nonessential amino acids, 
and 25 mM or 35 mM sodium bicarbonate. Cells were incubated at 
37°C at 5 or 10% (v/v) CO2, respectively, with TNF- (30 ng ml−1) for 
20 hours before lysis with M-PER extraction reagent and fluorescence 
counting in a microplate reader.
Immunoprecipitation
Antibody immunoprecipitation columns were produced using the 
Pierce Coimmunoprecipitation Kit (Thermo Fisher Scientific). Brief-
ly, aminolink coupling resin was washed with coupling buffer and 
incubated with 70 g of -Ub antibody (Abcam ab134953) and sodium 
cyanoborohydride for 2 hours at room temperature with mixing. The 
column was washed and incubated with quenching buffer and sodium 
cyanoborohydride for 30 min with mixing. The column was washed 
and stored at 4°C before immediate use. Cells were incubated at 37°C 
with 5 or 10% (v/v) CO2, respectively, with TNF- (30 ng ml−1) for 
20 hours before lysis with M-PER extraction reagent (Thermo Fisher 
Scientific, 78501). Input Western blots were carried out as described 
using 5 g of total cell lysate and probed with both -Ub and -IB 
antibodies. Input material for immunoprecipitation was normalized 
to total protein assessed by Bradford assay. Cell lysate from the same 
experiment was incubated with the -Ub resin overnight at 4°C with 
rolling. Columns were centrifuged at 500g for 30 s to remove buffer, 
samples were eluted with 50 l of elution buffer (pH 2.8), and the pH 
was neutralized with the addition of 1 M tris (pH 9.5). Eluted sam-
ples were then probed using an -IB antibody and the described 
Western blot protocol.
p65 assay
NF-B nuclear p65 was assayed by enzyme-linked immunosorbent assay 
(ELISA) (abcam133112) according to the manufacturer’s instructions.
SUPPLMENTARY MATERIALS
Supplementary material for this article is available at https://science.org/doi/10.1126/
sciadv.abi5507
View/request a protocol for this paper from Bio-protocol.
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